These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22152994)

  • 1. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
    Thöne J; Ellrichmann G; Seubert S; Peruga I; Lee DH; Conrad R; Hayardeny L; Comi G; Wiese S; Linker RA; Gold R
    Am J Pathol; 2012 Jan; 180(1):267-74. PubMed ID: 22152994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the mechanism of laquinimod action.
    Brück W; Wegner C
    J Neurol Sci; 2011 Jul; 306(1-2):173-9. PubMed ID: 21429524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
    Aharoni R; Saada R; Eilam R; Hayardeny L; Sela M; Arnon R
    J Neuroimmunol; 2012 Oct; 251(1-2):14-24. PubMed ID: 22749337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
    Jolivel V; Luessi F; Masri J; Kraus SH; Hubo M; Poisa-Beiro L; Klebow S; Paterka M; Yogev N; Tumani H; Furlan R; Siffrin V; Jonuleit H; Zipp F; Waisman A
    Brain; 2013 Apr; 136(Pt 4):1048-66. PubMed ID: 23518712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
    Ruffini F; Rossi S; Bergamaschi A; Brambilla E; Finardi A; Motta C; Studer V; Barbieri F; De Chiara V; Hayardeny L; Comi G; Centonze D; Martino G
    Mult Scler; 2013 Jul; 19(8):1084-94. PubMed ID: 23232603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod.
    Mishra MK; Wang J; Silva C; Mack M; Yong VW
    Am J Pathol; 2012 Aug; 181(2):642-51. PubMed ID: 22749771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
    Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
    PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
    Runström A; Leanderson T; Ohlsson L; Axelsson B
    J Neuroimmunol; 2006 Apr; 173(1-2):69-78. PubMed ID: 16472873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
    Yang JS; Xu LY; Xiao BG; Hedlund G; Link H
    J Neuroimmunol; 2004 Nov; 156(1-2):3-9. PubMed ID: 15465591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
    Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
    Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
    J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laquinimod enhances central nervous system barrier functions.
    Lühder F; Kebir H; Odoardi F; Litke T; Sonneck M; Alvarez JI; Winchenbach J; Eckert N; Hayardeny L; Sorani E; Lodygin D; Flügel A; Prat A
    Neurobiol Dis; 2017 Jun; 102():60-69. PubMed ID: 28235673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Pi R; Liu M; Ma X; Jiang Y; Liu Y; Mao X; Hu X
    J Neuroimmunol; 2010 Sep; 226(1-2):104-9. PubMed ID: 20538348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.
    Javeri S; Rodi M; Tary-Lehmann M; Lehmann PV; Addicks K; Kuerten S
    Clin Immunol; 2010 Nov; 137(2):181-9. PubMed ID: 20797911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
    Wegner C; Stadelmann C; Pförtner R; Raymond E; Feigelson S; Alon R; Timan B; Hayardeny L; Brück W
    J Neuroimmunol; 2010 Oct; 227(1-2):133-43. PubMed ID: 20684995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.